News | Stroke | August 26, 2024

AI Tool Helps Predict Stroke Outcomes

AI tool predicts stroke outcomes after arterial clot removal with 78% accuracy.

Aug. 23, 2024 — A team led by researchers at Yale School of Medicine has created a deep learning model that can accurately project post-surgical outcomes for some patients with large vessel occlusion (LVO) stroke using computed tomography angiography (CTA) scans taken at admission. 

"The deep learning model developed by our research team is the first step toward intelligent machinization of stroke neuroimaging protocol," said Sam Payabvash, M.D., Associate Professor of Radiology and Biomedical Imaging and senior author of the study. 

Using data from patients undergoing thrombectomy from 2014 to 2020, the Yale team trained three different models on admission CTA scans with and without data including time to surgery, age, sex and NIH stroke scale score. Researchers say the new tool would enable quick and accurate decision-making, with an established 'treatment trigger' to activate the treatment chain after surgery.

"We developed an end-to-end fully automated deep learning model that can predict stroke outcomes from readily available admission brain images and treatment success scenarios, with 78% accuracy in independent validation," Payabvash said.

"It’s worth noting that the model can solely rely on CT angiography scans of the brain, which are invariably present at the time of stroke diagnosis," he added. "Therefore, our model based on imaging information can provide rapid, objective predictions regardless of local expertise and other variabilities, guiding treatment in resource challenged communities.”

 


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now